In this video, Michael J. Bloch, MD, discusses the link between combined oral contraceptives and increased risk of arterial thrombosis, the risk of venous thromboembolic disease, and...
In this video, Michael J. Bloch, MD, discusses the link between combined oral contraceptives and increased risk of arterial thrombosis, the risk of venous thromboembolic disease, and...
In this video, Michael J. Bloch, MD, discusses the link between combined oral contraceptives and increased risk of arterial thrombosis, the risk of venous thromboembolic disease, and...
In this video, James Matera, DO, discusses the management of patients with primary hyperoxaluria (PH), including dietary modifications, hepatic and/or kidney transplantation, RNA interference agents,...
In this video, James Matera, DO, discusses the management of patients with primary hyperoxaluria (PH), including dietary modifications, hepatic and/or kidney transplantation, RNA interference agents,...
In this video, James Matera, DO, discusses the management of patients with primary hyperoxaluria (PH), including dietary modifications, hepatic and/or kidney transplantation, RNA interference agents,...
In this video, James Matera, DO, discusses the management of patients with primary hyperoxaluria (PH), including dietary modifications, hepatic and/or kidney transplantation, RNA interference agents,...
In this video, James Matera, DO, discusses the management of patients with primary hyperoxaluria (PH), including dietary modifications, hepatic and/or kidney transplantation, RNA interference agents,...
In this video, James Matera, DO, discusses the management of patients with primary hyperoxaluria (PH), including dietary modifications, hepatic and/or kidney transplantation, RNA interference agents,...
In this video, James Matera, DO, discusses the management of patients with primary hyperoxaluria (PH), including dietary modifications, hepatic and/or kidney transplantation, RNA interference agents,...
